High‐Performance Liquid Chromatography Determination of Latanoprost in Pharmaceutical Formulations using UV Detection

References

• Basu , S. , Sjoquist , B. , Stjernschantz , J. and Resul , B. 1994 . Corneal permeability to and ocular metabolism of phenyl substituted prostaglandin esters in vitro . Prostaglandins Leukotrienes Essent Fatty Acids , 50 : 161 – 168 .
   PubMed Web of Science ®Google Scholar
• Camaras , C. 1996 . Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma . Opthalmol. , 103 : 138 – 147 .
   PubMedGoogle Scholar
• Higaki , K. , Kamata , K. , Takeuchi , M. , Inazawa , K. , Toshiyuki , C. , Hamaguchi , T. , Yukawa , T. , Kadono , K. , Kawahara , S. and Nakano , M. 1995 . Ocular absorption, distribution, and systemic absorption of a novel antiglaucoma medication, prostaglandin derivative, in male white rabbits . Drug Metab. Dispos. , 23 : 35 – 43 .
   PubMed Web of Science ®Google Scholar
• Morgan , P. V. , Proniuk , S. , Blanchard , J. and Noecker , R. J. 1999 . Effect of temperature and light on the stability of latanoprost and its clinical relevance . Arzneimittelforschung. , 49 ( 3 ) : 225 – 233 .
   PubMedGoogle Scholar
• Redulescu , V. , Doneanu , C. , Mandruta , C. and Cocu , F. 1997 . HPLC analysis of some synthetic prostaglandin compounds of therapeutic interest . Rev. Roum. Chim. , 42 ( 12 ) : 1129 – 1135 .
   Google Scholar
• Serle , J. B. 1994 . Pharmacological advances in the treatment of glaucoma . Drugs and Ageing , 5 : 156 – 176 .
   PubMedGoogle Scholar
• Sjoquist , B. , Tajallaei , S. and Stjernschantz , J. 2005 . Pharmcokinetics of latanoprost in the cynomolgus monkey. 1st communication: single intravenous, oral or topical administration on the eye . Invest. Ophthalmol. Vis. Sci. , 46 ( 7 ) : 2444 – 2450 .
   PubMedGoogle Scholar
• Stjernschantz , J. and Resul , B. 1992 . Latanoprost as a new horizon in medical treatment of glaucoma . Curr. Opin. Ophthalmol. , 7 : 11 – 17 .
   Google Scholar
• Watson , P. 1998 . Latanoprost—Two years' experience of its use in the United Kingdom . Opthalmol. , 105 : 82 – 87 .
   PubMed Web of Science ®Google Scholar